Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1579-1584

  Montravers, Philippe ^a,b   Maulin, Laurence ^a   Mohler, Jacqueline ^a   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; INFLAMMATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROBIOLOGY; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RAT; SUPERINFECTION;

EID: 0033002660     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.4.1579-1584.1999     Document Type: Article

References (41)

1. Ayala, A., D. L. Lehman, C. D. Herdon, and I. H. Chaudry. 1994. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch. Surg. 129:1172-1178.
2. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
3. Bean, A. G., R. A. Freiberg, S. Andrade, S. Menon, and A. Zlotnik. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61:4937-4939.
4. Berg, D. J., K. Kühn, K. Rajewsky, W. Müller, S. Menon, N. Davidson, G. Grünig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Schwartzman reaction but not endotoxin tolerance. J. Clin. Investig. 96:2339-2347.
5. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffela, P. Puccetti, and F. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23: 1034-1038.
6. Contrepois, A., J. M. Vallois, J. J. Garaud, B. Pangon, J. Mohler, A. Meulemans, and C. Carbon. 1986. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. J. Antimicrob. Chemother. 17:227-237.
7. Cox, G. 1996. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am. J. Physiol. 271:L566-L571.
8. Cross, A. S., S. M. Opal, J. C. Sadoff, and P. Gemski. 1993 Choice of bacteria in animal models of sepsis. Infect. Immun. 61:2741-2747.
9. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
10. Dupont, H., P. Montravers, J. Mohler, and C. Carbon. 1998. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect. Immun. 66:2570-2575.
11. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
12. Florquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618-2623.
13. Gérard, C., C. Bryuns, and A. Marchant. 1993. IL-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
14. Gomez-Jimenez, J., M. C. Martin, R. Sauri, R. M. Segura, F. Esteban, J. C. Ruiz, X. Nuvials, J. L. Boveda, R. Peracaula, and A. Salgado. 1995. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J. Infect. Dis. 171:472-475.
15. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodmen, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722-729.
16. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
17. Jacob, A. E., and S. J. Hobbs. 1974. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117:360-372.
18. Kato, T., A. Murata, H. Ishida, H. Toda, N. Tanaka, H. Hayashida, M. Monden, and N. Matsuura. 1995. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39:1336-1340.
19. Kelton, J. G., R. Ulan, C. Stiller, and E. Holmes. 1978. Comparison of chemical composition of peritoneal fluid and serum: a method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo. Ann. Intern. Med. 89:67-70.
20. Koedel, V., A. Bernatowicz, K. Frei, A. Fontana, and H. W. Pfister. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:5185-5191.
21. Marchant, A., J. Deviere, B. Byl, D. De Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
22. Montravers, P., A. Andremont, L. Massias, and C. Carbon. 1994. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J. Infect. Dis. 169:821-830.
23. Montravers, P., J. Mohler, L. Saint-Julien, and C. Carbon. 1997. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect. Immun. 65:144-149.
24. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230-1234.
25. Mosmann, T. 1994. Properties and functions of interleukin 10. Adv. Immunol. 56:1-26.
26. Mosmann, T. R. 1994. Interleukin-10, p. 223-237. In A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press Ltd., London, England.
27. Mulligan, M. S., M. L. Jones, and A. A. Vaporciyan. 1993. Prospective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151:5666-5674.
28. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. 1994. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-783.
29. Opal, S. M., C. J. Fisher, J. F. Dhainaut, J. L. Vincent, R. Erase, S. F. Lowry, J. C. Sadoff, G. J. Slotman, H. Levy, R. A. Balk, M. P. Selly, J. P. Pribble, J. F. LaBrecque, J. Lookabaugh, H. Donovan, H. Dubin, R. Baughman, E. DeMaria, K. Matzel, E. Abraham, and M. Seneff. 1997. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit. Care Med. 25:1115-1124.
30. Pajkrt, D., L. Camoglio, M. C. Tiel-van Buul, K. de Bruin, D. L. Cutler, M. B. Affrime, G. Rikken, T. van der Poll, J. W. Ten Cate, and S. J. van Deventer. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158:3971-3977.
31. Paris, M. M., S. Mickey, M. Trujillo, A. Ahmed, K. Olsen, and G. H. McCracken. 1997. The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. J. Infect. Dis. 176:1239-1246.
32. Shoemaker, W. C., P. L. Appel, H. B. Kram, M. H. Bishop, and E. Abraham. 1993. Sequence of physiologic patterns in surgical septic shock. Crit. Care Med. 21:1876-1889.
33. Steel, R. G. D., and J. H. Tovrie. 1987. Principles and procedures of statistics: a biometrical approach. McGraw-Hill, New York, N.Y.
34. Van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175:118-122.
35. Van der Poll, T., J. Jansen, M. Levi, H. Ten Cate, J. Ten Cate, and S. Van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1988.
36. Van der Poll, T., P. M. Jansen, W. J. Montegut, C. C. Braxton, S. E. Calvano, S. A. Stackpole, S. R. Smith, S. W. Swanson, C. E. Hack, S. F. Lowry, and L. Moldawer. 1997. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1971-1975.
37. Van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401.
38. Van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994-1000.
39. Van Deventer, S. J., C. O. Elson, and R. N. Fedorak. 1997. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 113:383-389.
40. Weinstein, W. M., A. B. Onderdonk, J. G. Bartlett, and S. L. Gorbach. 1974. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect. Immun. 10:1250-1255.
41. Zanetti, G., D. Heumann, J. Gerain, J. Kohler, P. Abbet, C. Barras, R. Lucas, M. P. Glauser, and J. D. Baumgartner. 1992. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J Immunol. 148:1890-1897.